Amneal Pharmaceuticals, Inc. AMRX Change in Inventories
Change in Inventories at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s change in inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s change in inventories?
- Amneal Pharmaceuticals, Inc. (AMRX) reported change in inventories of $54.96M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s change in inventories changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s change in inventories increased by 314.4% year-over-year, from $13.26M to $54.96M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s change in inventories?
- Over 3 years (2022 to 2025), Amneal Pharmaceuticals, Inc.'s change in inventories has grown at a -5.3% compound annual growth rate (CAGR), from $102.4M to $87.03M.
- What does change in inventories mean?
- Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.